• Latest Posts

With €200 Million, Cellectis is on its way to make the Biggest French Biotech IPO ever

The Metamorphosis of Biopharmaceutical Innovation #BIO-Europe2015

Apceth Initiates Phase II for its pioneering Engineered Cell Therapy to treat Gastrointestinal Cancer

The Genomic Portrait of Iceland

Epigenomics’ proColon, the non-invasive blood-based test for colorectal cancer

ADVERTISEMENT

The Institut Pasteur and IntegraGen, allies to Strengthen High-Throughput Sequencing in Microbiology

Rigontec and its revolutionary RNA-based immunotherapeutics raise €4.8 Million

Life Sciences have a new big player: Joint Polish Investment Fund Management

AOP Orphan and Confluence Pharmaceuticals, together for Fragile X Syndrome

A Vaccine against Placental Malaria made with ExpreS2ion’s Protein Expression Technology

#BioFigures: 12 Key French Players launch New Immunotechnology Reference Center MI-mabs

ADVERTISEMENT